MediBeacon device earns ‘breakthrough’ designation from FDA
October 22, 2018 at 07:42 AM EDT
The U.S. Food and Drug Administration has granted its breakthrough device designation to St. Louis-based MediBeacon’s transdermal GFR measurement system to aid in the fight against kidney disease.
